Susquehanna International Group’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-22,417
| Closed | -$642K | – | 10479 |
|
|
2018
Q4 | $642K | Buy |
+22,417
| New | +$637K | ﹤0.01% | 5542 |
|
|
2018
Q1 | – | Sell |
-54,329
| Closed | -$1.32M | – | 10699 |
|
|
2017
Q4 | $1.32M | Buy |
54,329
+5,969
| +12% | +$157K | ﹤0.01% | 4692 |
|
|
2017
Q3 | $1.33M | Sell |
48,360
-147,013
| -75% | -$3.92M | ﹤0.01% | 4711 |
|
|
2017
Q2 | $4.9M | Buy |
195,373
+182,005
| +1,361% | +$4.51M | ﹤0.01% | 2441 |
|
|
2017
Q1 | $359K | Sell |
13,368
-99,901
| -88% | -$2.76M | ﹤0.01% | 7065 |
|
|
2016
Q4 | $2.97M | Buy |
+113,269
| New | +$2.8M | ﹤0.01% | 3259 |
|
|
2016
Q3 | – | Sell |
-30,891
| Closed | -$720K | – | 9391 |
|
|
2016
Q2 | $670K | Sell |
30,891
-20,078
| -39% | -$358K | ﹤0.01% | 5614 |
|
|
2016
Q1 | $764K | Buy |
+50,969
| New | +$854K | ﹤0.01% | 5625 |
|
|
2015
Q4 | – | Sell |
-31,435
| Closed | -$496K | – | 10287 |
|
|
2015
Q3 | $496K | Buy |
31,435
+18,682
| +146% | +$300K | ﹤0.01% | 7139 |
|
|
2015
Q2 | $182K | Sell |
12,753
-3,244
| -20% | -$54.9K | ﹤0.01% | 9361 |
|
|
2015
Q1 | $277K | Sell |
15,997
-10,431
| -39% | -$184K | ﹤0.01% | 8120 |
|
|
2014
Q4 | $474K | Buy |
26,428
+12,456
| +89% | +$201K | ﹤0.01% | 7311 |
|
|
2014
Q3 | $183K | Sell |
13,972
-63,279
| -82% | -$852K | ﹤0.01% | 8758 |
|
|
2014
Q2 | $1.11M | Buy |
77,251
+60,760
| +368% | +$793K | ﹤0.01% | 5827 |
|
|
2014
Q1 | $210K | Sell |
16,491
-1,524
| -8% | -$19.9K | ﹤0.01% | 8160 |
|
|
2013
Q4 | $180K | Buy |
+18,015
| New | +$204K | ﹤0.01% | 8346 |
|
Other funds holding NXTM
Susquehanna International Group's NXTM Position: Q1 2019 in Review
Susquehanna International Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 22,417 shares — an estimated $642K sold.
Susquehanna International Group first reported a position in NXTM in Q4 2013 and held it in 16 quarters. The position peaked at $4.9M in Q2 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Susquehanna International Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Susquehanna International Group sold 22,417 NxStage Medical Inc. shares in Q1 2019, an estimated $642K.
- Susquehanna International Group first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 16 quarters.
- Susquehanna International Group's NxStage Medical Inc. position peaked at $4.9M in Q2 2017.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.